Lab Quality & Testing
Water Content and Counter-Ions in Lyophilized Peptides
A lyophilized vial is rarely 100% peptide. Residual water and counter-ions explain why — and why net content and purity are different numbers.
Published October 4, 2026 · 6 min read
By Novanta Research Editorial Team
Evidence scope: Analytical evidence only. Composition data describe the material in the vial and do not establish biological activity, clinical safety or suitability for human use.
Where the non-peptide mass comes from
Peptides purified by reversed-phase chromatography are typically isolated as salts. Trifluoroacetate from the mobile phase pairs with protonated basic residues, so a sequence rich in lysine and arginine carries proportionally more counter-ion mass.
Lyophilized cake also retains adsorbed water. The powder is hygroscopic, and water content rises if the vial is opened in humid air or stored without desiccation.
Sources for this section
- Towards a Consensus for the Analysis and Exchange of TFA as a Counterion in Synthetic Peptides — Pharmaceuticals, 2025
Why the distinction matters in the laboratory
HPLC area-percent purity compares the target peak with other detected peaks; it says nothing about how much of the vial's total mass is peptide at all. Net peptide content answers that question with a separate assay.
A solution prepared from labelled mass alone can be systematically over-concentrated in the researcher's records. Where a lot-specific certificate reports net content, that documented figure is the defensible input for concentration calculations.
Counter-ion exchange
Counter-ions can be exchanged — acetate for trifluoroacetate, for example — but the exchange changes the salt form and therefore the mass balance of the material. A certificate should state the salt form it describes.
For research purposes the practical rule is simple: record the salt form, the water content where reported, and the net peptide content, and treat a change in any of them as a change of material.
Sources for this section
- Towards a Consensus for the Analysis and Exchange of TFA as a Counterion in Synthetic Peptides — Pharmaceuticals, 2025
Keep reading
For laboratory and research use only. Not for human or veterinary consumption. Novanta Research is not a compounding pharmacy and nothing in this article is medical advice or a claim that any compound diagnoses, treats, cures or prevents any condition.